The global eyeglasses market is projected to grow at a rate of 7% over the next five years, driven by several key factors. These include the rising prevalence of refractive errors and vision disorders ...
The primary applications of virtual reality in ophthalmology include physician and patient education, diagnostic testing in ...
As red-light laser therapy gains popularity in Asia for slowing myopia in children, reports of vision damage have emerged, ...
As red-light laser therapy gains popularity in Asia for slowing myopia in children, reports of vision damage have emerged, ...
Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...
The policy further expands access to Luminopia's engaging, FDA-cleared treatment for children with lazy eye CAMBRIDGE, Mass., Feb. 25, 2026 /PRNewswire/ -- Luminopia, Inc., a digital health company ...
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
Cornerstone Eye Associates has become the first practice in Rochester to offer Valeda Light Therapy for the treatment of dry macular degeneration. The new Food and Drug Administration-approved ...
ROCHESTER, N.Y. (WROC) — Cornerstone Eye Associates has become the first practice in Rochester to offer Valeda Light Therapy for the treatment of dry macular degeneration. The new Food and Drug ...
The US Food and Drug Administration (FDA) has approved a Phase 1 clinical trial from Life Biosciences that aims to help certain eye cells act younger and improve vision in glaucoma and related ...
Preliminary results from the Phase 2 ArMaDa clinical trial indicate a 46% reduction in lesion growth compared to the control group after 12 months, with no serious adverse events reported across both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results